Skip to main content
. 2018 Mar 30;9(24):16822–16831. doi: 10.18632/oncotarget.24706

Table 2. Response to treatment.

During induction Post-induction After first line
Complete response 18 (72%) 16 (64%) 19 (76%)
Partial response 4 (16%) 0 0
Stable Disease 2 (8%) 0 0
Progressive Disease 1 (4%) 5 (20%) 5 (20%)
MRI not done 0 4 (16%)* 1 (4%)

Reported here are the best responses achieved during induction, responses after induction and at the end of the first line of treatment. Patients with stable or progressive disease during or after induction were switched to various salvage therapies. *MRI not done due to treatment unrelated death (n = 1), protocol deviation (n = 3); treatment unrelated death (n = 1).